Global Drug Discovery Informatics Market, By Function (Sequencing and Target Data Analysis, Docking, Molecular Modeling, Library and Database Preparation, Others), Solutions (Software, Services), Workflow (Drug Discovery, Drug Development), Mode (In-House Informatics, Outsourced Informatics), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Drug discovery informatics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 5.42 billion by 2028 and will grow at a CAGR of 11.77% in the above mentioned forecast period.
Drug discovery informatics make use sophisticated bioinformatics algorithms to process data related to drug, protein, disease, pathway, gene expression and also to sequence data and widen the flexible architecture to make new customized approaches and algorithms for various aspects of drug discovery which would facilitate to diminish the cost for drug development.
The increasing research spending on informatics by the pharmaceutical and biotechnology industries is amongst the important factors intensifying the growth and demand of drug discovery informatics market. In addition, the rising demand and support for rare disease and orphan drug research and rising focus on drug discovery using informatics software are also contributing to the growth in the global market over the forecast period of 2021 to 2028. Also the introduction of novel insilico tools by some organizations as well as increasing chronic illness such as cardiovascular diseases, oncology, diabetes mellitus and other infectious diseases are also enhancing the growth of the market. Furthermore, the high progressions in software versions for processing, data aggregation and analysis and data visualization are also one of the significant factors fueling the growth of the drug discovery informatics market. Increased use for cloud based services will make sure high industry growth over the forecast period.
The increasing biotechnology industry and biologics market along with patent expiry and strong presence of leading pharmaceutical and biotechnology companies are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the high setup costs of informatics software and high installation cost will curb the growth of the drug discovery informatics market, whereas the lack of skilled professionals has the potential to challenge the growth of the drug discovery informatics market.
This drug discovery informatics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on drug discovery informatics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Drug Discovery Informatics Market Scope and Market Size
Drug discovery informatics market is segmented on the basis of function, solutions, workflow, mode and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on function, the drug discovery informatics market is segmented into sequencing and target data analysis, docking, molecular modeling, library and database preparation and others. Others have further been segmented into screening and ADMET characterization.
- On the basis of solutions, the drug discovery informatics market is segmented into software and services.
- On the basis of workflow, the drug discovery informatics market is segmented into drug discovery and drug development. Drug discovery has further been segmented into identification and validation informatics assay development informatics and lead generation information processing. Drug development has further been segmented into lead optimization, FHD preparation, phase IA and phase IB/2.
- Based on mode, the drug discovery informatics market is segmented into in-house informatics and outsourced informatics.
- The end user segment of drug discovery informatics market is segmented into pharmaceutical and biotechnology companies, contract research organizations (CROS) and others.
Drug Discovery Informatics Market Country Level Analysis
Drug discovery informatics market is analyzed and market size insights and trends are provided by country, function, solutions, workflow, mode and end user as referenced above.
The countries covered in the drug discovery informatics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the drug discovery informatics market owing to the high incidence rates of different infectious diseases and oncology diseases as well as high growth of next generation sequencing and chemical laboratories within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the presence of drug nanotechnology sector and ongoing research in software within this particular region.
The country section of the drug discovery informatics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Drug discovery informatics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for drug discovery informatics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug discovery informatics market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Drug Discovery Informatics Market Share Analysis
Drug discovery informatics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to drug discovery informatics market.
The major players covered in the drug discovery informatics market report are Jubilant Biosys, IBM, Infosys Limited, Eurofins Scientific, Thermo Fisher Scientific, PerkinElmer Inc., Schrödinger, Inc., Dassault Systèmes, Charles River Laboratories, Selvita, Certara, GVK Biosciences Private Limited, Collaborative Drug Discovery, Inc, OpenEye Scientific Software, IO Informatics, Inc., Albany Molecular Research Inc., Accenture, Cognizant, Insilico Medicine and Boehringer Ingelheim International GmbH among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Drug Discovery Informatics Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.